{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:59:38Z","timestamp":1768179578398,"version":"3.49.0"},"reference-count":20,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["GNT1194667"],"award-info":[{"award-number":["GNT1194667"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031198","name":"Department of Health Western Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100031198","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Experimental Optometry"],"published-print":{"date-parts":[[2026,1,2]]},"DOI":"10.1080\/08164622.2025.2458171","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T10:12:34Z","timestamp":1743761554000},"page":"60-66","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Readiness of optometrists in the management of geographic atrophy: a survey of optometrists in Australia"],"prefix":"10.1080","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9441-4356","authenticated-orcid":false,"given":"Robyn H","family":"Guymer","sequence":"first","affiliation":[{"name":"Royal Victorian Eye and Ear Hospital","place":["East Melbourne, Australia"]},{"name":"The University of Melbourne","place":["Melbourne, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8182-6167","authenticated-orcid":false,"given":"Alex P","family":"Hunyor","sequence":"additional","affiliation":[{"name":"The University of Sydney","place":["Sydney, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2809-9930","authenticated-orcid":false,"given":"Fred K","family":"Chen","sequence":"additional","affiliation":[{"name":"University of Western Australia","place":["Perth, Australia"]},{"name":"Royal Perth Hospital","place":["Perth, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2491-685X","authenticated-orcid":false,"given":"Lyndell L","family":"Lim","sequence":"additional","affiliation":[{"name":"Royal Victorian Eye and Ear Hospital","place":["East Melbourne, Australia"]},{"name":"The University of Melbourne","place":["Melbourne, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8065-9715","authenticated-orcid":false,"given":"Jennifer","family":"Arnold","sequence":"additional","affiliation":[{"name":"Marsden Eye Specialists","place":["Parramatta, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1432-8977","authenticated-orcid":false,"given":"Carla J","family":"Abbott","sequence":"additional","affiliation":[{"name":"Royal Victorian Eye and Ear Hospital","place":["East Melbourne, Australia"]},{"name":"The University of Melbourne","place":["Melbourne, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"e_1_3_4_2_1","unstructured":"RANZCO referral pathway for AMD management. 2024 Apr. RANZCO. [accessed 2024 Apr 27]. https:\/\/ranzco.edu\/policies_and_guideli\/ranzco-referral-pathway-for-amd-management\/. 27 Apr 2024"},{"key":"e_1_3_4_3_1","unstructured":"Iveric Bio Receives U.S. FDA approval for IZERVAYTM (avacincaptad pegol intravitreal solution) a new treatment for geographic atrophy. 2023 Aug. Astellas Pharmaceuticals Inc. [accessed 2023 Sep 1]. https:\/\/www.astellas.com\/en\/news\/28281."},{"key":"e_1_3_4_4_1","unstructured":"Apellis receives approval of SYFOVRE (pegcetacoplan) in Australia for geographic atrophy (GA). 2025 Jan. Apellis Pharmaceuticals Inc. [accessed 2025 Mar 17]. http:\/\/www.investors.apellis.com\/news-releases\/news-release-details\/apellis-receives-approval-syfovrer-pegcetacoplan-australia."},{"key":"e_1_3_4_5_1","unstructured":"FDA approves SYFOVRETM (pegcetacoplan injection) as the first and only treatment for geographic atrophy (GA) a leading cause of blindness. 2023. Apellis Pharmaceuticals Inc. [accessed 2023 Feb 17]. https:\/\/investors.apellis.com\/news-releases\/news-release-details\/fda-approves-syfovretm-pegcetacoplan-injection-first-and-only."},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.14304"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/08164622.2024.2361752"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2017.4182"},{"key":"e_1_3_4_9_1","first-page":"1500","article-title":"Efficacy of intravitreal pegcetacoplan in patients with geographic atrophy (GA): 12-month results from the phase 3 OAKS and DERBY studies","volume":"63","author":"Goldberg R","year":"2022","unstructured":"Goldberg R, Heier JS, Wykoff CC et al. Efficacy of intravitreal pegcetacoplan in patients with geographic atrophy (GA): 12-month results from the phase 3 OAKS and DERBY studies. Invest Ophthalmol Vis Sci 2022; 63: 1500.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01520-9"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01583-0"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-023-02548-2"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2022.08.022"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.10.036"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.11.023"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.08.038"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02609-5"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.09.028"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.06.034"},{"key":"e_1_3_4_20_1","unstructured":"Optometry Board of Australia registrant data table - March 2024. 2024 May. Optometry Board of Australia. [accessed 2024 Jun 23]. https:\/\/www.optometryboard.gov.au\/About\/Statistics.aspx."},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2020.02.016"}],"container-title":["Clinical and Experimental Optometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/08164622.2025.2458171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T22:06:43Z","timestamp":1768169203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/08164622.2025.2458171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"alternative-id":["10.1080\/08164622.2025.2458171"],"URL":"https:\/\/doi.org\/10.1080\/08164622.2025.2458171","relation":{},"ISSN":["0816-4622","1444-0938"],"issn-type":[{"value":"0816-4622","type":"print"},{"value":"1444-0938","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=tceo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=tceo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-10-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}